The role of polymorphisms in metalloproteinases (MMP3-MMP9, ADAM33) and their inhibitors (TIMP2 and TIMP3) in the onset and severity of COPD in smokers has been reported21, 22. This evidence concerns the gene MMP3 and chronic obstructive pulmonary disease.